What is it about?
Resistance makes antibiotics ineffective. Antibiotics are often prescribed without laboratory examination of resistance. Such an empirical treatment is only feasible if the background resistance to antibiotics is generally low. This study examines the performance of a novel way to assess antimicrobial resistance in the community.
Featured Image
Why is it important?
Conventional surveys to assess the occurrence of resistance are costly, time consuming, and can not identify local variations of resistance in the community. Therefore, there is a high chance that prescribed antibiotics are not working properly in a lareg group of patients. This new method can overcome all these problems ad contribute to improved patient care.
Read the Original
This page is a summary of: Rapid assessment of antimicrobial resistance prevalence using a Lot Quality Assurance sampling approach, Future Microbiology, April 2017, Future Medicine,
DOI: 10.2217/fmb-2016-0170.
You can read the full text:
Resources
LQAS-based surveillance identifies local variations in drug resistance
LQAS-based surveillance of resistance for anti-tuberculosis drugs, using retrospective data from conventional community-based surveys in three countries. The study shows how this approach can identify local variations otherwise hidden in aggregate estimates of drug resistance.
LQAS analysis framework
This discussion on an LQAS analysis clearly explains the framework in which the LQAS-approach fits
Contributors
The following have contributed to this page
